I r r e v e r s i b l e mental retardation occurs i n transferase deficiency galactosemia. Because of the documented a l t e r a t i o n of CNS levels of f r e e and lipid-bound i n o s i t o l i n the disorder,we have examined the metabolism of phosphatidylinositol (PhI) i n isolated brain synaptosomes of galactose toxic r a t s . Emphasis has been on the e f f e c t s of acetylcholine (Ach) since enhanced PhI turnover i s seen i n response t o neurotransmitters. Experimental galactose t o x i c i t y was produced by feeding a 40% galactose d i e t t o weanling r a t s . Cortical synaptosomes were prepared from control and galactose toxic r a t s from 37-83 days of age and incubated f o r 40 min with 3 3~0~ and [ 3~] -i n o s i t o l i n the presence or absence of Ach. Phospholipids were extracted from synaptosomal membranes; G C analysis was employed t o determine chemical levels (nmolelmg protein) and s p e c i f i c r a d i o a c t i v i t i e s (dpmlpeak area). Ach stimulation of synaptosomes from control and galactose toxic r a t s produced similar changes i n PhI levels and 3 3~0 4 incorporation i n t o PhI, however, synaptosomes from galactose toxic r a t s showed a 50% decrease i n I3H]-inositol labeling of PhI compared t o control synaptosomes. This abnormality i n PhI metabolism could be important i n the CNS disturbances associated with galactose toxic s t a t e s .
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THE ARRHENIUS PLOT OF HEPATIC MICROSOMAL GLUCOSE-6-PHOSPHATASE ACTIVITY OF THE CONGENITALLY JAUNDICED
'loo (GUNN) RAT. Dennis D. Black and Peter F. Whitin ton.
(Spon. by John F. G r i f f i t h ) . University of Tennessee centergfor Health Sciences, Department of Pediatrics, and LeBonheur Childr e n ' s Medical Center, Memphis, TN 38163.
The f a i l u r e of the Gunn r a t t o conjugate bilirubin r e s u l t s from e i t h e r defective ( o r absent) bi 1 i rubin UDP-gl ucuronyl transferase o r from a defect in the membrane environment of t h a t enzyme. The l a t t e r p o s s i b i l i t y was investigated by constructing Arrhenius plots from 38-8'~ of microsomal glucose-6-phosphatase a c t i v i t y of Gunn ( j j , n = 6 ) , Wistar (JJ,n=9) and heterozygote (Jj,n=8) r a t s . This enzyme was studied because the Gunn r a t i s not defective i n glucose-6-phosphatase, and t h i s enzyme i s t i g h t l y bound t o the microsome. The plots of j j , J j and J J were identical in the f o llowing ways: a ) the s p e c i f i c a c t i v i t y a t 3 7 '~ was 2.51 pmol hydrolyzedlmg protein110 min indicating no j j defect in enzyme a c t i v it y ; b) there was a change in slope a t 3 5 '~ probably indicating a change i n protein structure; c ) the energy of activation was 12800 cal/mol. However, a c l e a r difference was observed i n the following way: J J demonstrated a discontinuous plot indicating a l i p i d phase change a t l l '~, but the plot of j j was a continuous s t r a i g h t l i n e t o 8 '~. Jj exhibited an intermediate discontinuity a t 8 '~. Two infants presented with fine brittle hair with characteristic kinking. Their clinical course was characterized by neurological degeneration and a tendency to gain weight. In Case 1 1 (6 m. male) the S. copper was 5.09 ugldl (80-120) and ceruloplasmin 2.44 ugldl (20-50). I.V. GTT demonstrated glucose intolerance with K values of 0.81 and 0.825 but with an insulin peak of 35 uU/ml. Triglyceride TG=66 mgldl and cholesterol TC=178 mg/dl (normal TG=73+37, TC=150+25). Apoliproteins (Apo's) were Apo AI, 97.4 mgldl and Apo B, 110.9 mgTdl. In Case 1 2 (13 m. male) the S. copper was 12.7 ugldl and ceruloplasmin 1.58 mgldl. The I.V. GTT K rate was 1.98; TG, 149 mgldl; TC, 160 mgldl; Apo's AI, 100.2 mgldl; AII, 51.7 mgldl; 8, 110.6 mgldl; CIII, 10.5 mgldl; E, 7.0 mgldl; post-heparin lipoprotein lipase activity was 14.94+3.62 and triglyceride lipase activ~ty 10.94+4.63 units per ml per hour uzn heparin sepharose affinity chromatography for enzyme separation and f4C labeled triolein as substrate (young adult normal LPL=14.9+3.6, TGL=10.9+4.6). Lipoprotein separation revealed a predominant incyease in TG, T c and Apo B in VLDL in Case 2. Double diffusion analysis and crossed electrophoresis against anti-Apo B on agarose gels revealed normal immunoprecipitin lines. We conclude that in Menkes' disease, copper deficiency may cause secondary hyperlipidemia as suggested by Allen, K.G.D. and Klevay L.M. (Life Sciences 22, 1691 , 1978 .
HEPATIC GLUCOSE METABOLISM AND GLYCOGENOLYTIC RESPONSE TO HYPOXIA I N FETAL LAMBS. J. Bristow, A . Rudol h,
' 'lo' R . Barnes, J . Itskovitz, U.CA., CVRI, San Franci:co.
To assess the r o l e of the l i v e r i n glucose (G) metabolism, we studied G flux across the l i v e r i n 7 f e t a l lambs (118-123 days) 2-5 days a f t e r catheterization of descending aorta (AO), i n f e r i o r vena cava (IVC), umbilical vein ( W ) , p o r t a l vein (PV), and r i g h t (RHV), l e f t (LHV), o r both hepatic veins. Blood flow t o each l i v e r lobe from hepatic a r t e r y , W and PV were measured by injections of microspheres i n t o IVC, PV, and W. G concentrations were measured i n a l l s i t e s and G consumption (OG) was measured by the Fick method. Studies were done before and during maternal hypoxemia. G concentrations (mgldl) 104 children with IDDM were examined f o r induration and thickening of the skin and f o r j o i n t contractures. Five pat i e n t s had both multiple j o i n t involvement and skin changes; 3 were studied in d e t a i l . Their diabetes ranged from 7-16 years i n duration and was characterized by short s t a t u r e , hepatomegaly, 4 t o 6 hospitalizations each year, and glucosylated Hgb levels of 12-16%. All 3 had r e s t r i c t i v e pulmonary lung disease.
Histopathology of skin biopsies (bxs) demonstrated increased accumulation of collagen i n the lower dermis. Three skin bxs were homogenized and compared t o 6 bxs from age matched controls.
The e x t r a c t a b i l i t y of collagen i n 0.5 N a c e t i c acid was decreased t o about J., normal i n 2 of the patients, suggesting increased cross-linkage of collagen. The amount of hexose bound t o protein i n a ketoamine linkage was assayed a s the 5-hydroxymethylfurfural derivative. In patients, the mean non-enzymatic gl ucosylation was 4.0 (range 0.9-8.5) ng hexose/ug hydroxyprol i n e which was 13 times t h a t of controls (mean=0.3, range 0.2-0.4, ng hexoselug hydroxyproline). The r e s u l t s suggest t h a t non-enzymatic glucosylation may a1 t e r the packing, cross-1 inking and turnover of collagen, thus contributing t o the development of a scleroderma-1 i ke cutaneous syndrome in IDDM. Asp and pred (40 mg/M2/day) were found t o a c t synergistically in producing hyperglycemia during leukemia remission induction. To explain the mechanism, glucose and insulin (~U / m l ) levels during oral glucose tolerance t e s t (OGTT) and erythrocyte insulin binding studies were performed s e r i a l l y during the course of therapy in an obese 8-year-old g i r l with Down's syndrome.
Days of Fasting % Insulin Receptor No. Average Affinity Pred Insulin binding (per c e l l ) Ke (100bl-1) *One day a f t e r Asp (10,000 units/M2)
Five days of pred therapy along resulted in hyperinsulinemia (594 pU/~nl) and decreased insulin binding without OGTT deterioration. Following Asp, fasting and postprandial glucose increased t o 241 and 514 mg/dl, respectively whereas insulin response was inadequate (peak < 130 pU/ml). These data suggest t h a t the mechanism of Asp and pred induced-hyperglycemia i s a combined e f f e c t of reduced insulin binding and impaired insulin production o r secretion ( o r both).
